People: Osiris Therapeutics Inc (OSIR.O)

OSIR.O on Consolidated Issue listed on NASDAQ Global Market

8.65USD
9 Feb 2010
Price Change (% chg)

$0.12 (+1.41%)
Prev Close
$8.65
Open
--
Day's High
$8.79
Day's Low
$8.51
Volume
71,921
Avg. Vol
161,515
52-wk High
$20.96
52-wk Low
$5.35

view people for:

Mills, C. Randall 

Brief Biography

Dr. C. Randal Mills is President and Chief Executive Officer of Osiris Therapeutics, Inc since July 2004. Dr. Mills has also been a member of Board since July 2004. Prior to joining Osiris, Dr. Mills was an executive officer of Regeneration Technologies, Inc. ("RTI") (NASDAQ—RTIX). Dr. Mills served in several leadership positions at RTI from its formation in 1998 until 2004, including Vice President of Business Development and Vice President of Operations and R&D. Prior to RTI, Dr. Mills was a member of the founding management team of the University of Florida Tissue Bank, Inc., the predecessor company to RTI. Dr. Mills received a bachelor's degree in microbiology and cell science and a Ph.D. in drug development, both from the University of Florida.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
688,829 -- 527,088 1,215,920

Options Compensation

  Quantity Market Value
Excercisable 150,000 --
Unexercisable 450,000 --
Excercised -- --
Name Fiscal Year Total
Friedli, Peter --
Mills, C. Randall 1,215,920
Jacoby, Philip 204,106
Debrabandere, Lode 388,664
Williams, Michelle 370,019
Gutzwiller, Felix --
As Of 30 Dec 2008
view people for: